• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

T Rowe Price Funds OEIC US Equity Fund C Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider T Rowe
Fund Summary To increase the value of its shares, over the long term, through growth in the value of its investments.
SEDOL code BD8G583
ISIN GB00BD8G5832
Fund code TWUEA
Managers Jeffrey Rottinghaus
Manager Tenure 3 years
Morningstar Category US Large-Cap Blend Equity
IMA Sector North America
Fund Size £7 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.82%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £13.1646
Buy Price £13.1646
Price Change -0.088%
Price Date 14th June 2019
Yield Currently unavailable
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 31st October 2016
Fund Status OPEN
Jeff Rottinghaus is a portfolio manager in the US Equity Division of T. Rowe Price. He is president of the US Large-Cap Core Equity and Growth & Income Strategies. Mr. Rottinghaus is a vice president of T. Rowe Price Group, Inc. Mr. Rottinghaus earned a B.S. in business administration from Bowling Green State University and an MBA in finance from the Wharton School, University of Pennsylvania. He is also a certified public accountant.

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2018 2017
Fund Performance +17.71% -2.43%
Benchmark Performance
(US Large-Cap Blend Equity)
+15.56% -2.49%
Time Period Cumulative Benchmark Performance
(US Large-Cap Blend Equity)
Fund Compared to Benchmark
1 day -0.09% -0.35% +0.26%
1 week 1.38% +2.39% -1.01%
1 month 5.88% +3.07% +2.80%
3 months 9.40% +6.45% +2.95%
6 months 9.75% +8.51% +1.24%
1 year 15.23% +8.48% +6.75%
3 years Currently unavailable +55.74% Currently unavailable
5 years Currently unavailable +96.12% Currently unavailable
10 years Currently unavailable +285.46% Currently unavailable
YTD 17.73% +16.00% +1.73%
Since inception 31.65% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Alphabet Inc Class C USA 3.66%
Microsoft Corp USA 3.61%
Amazon.com Inc USA 3.18%
Apple Inc USA 2.55%
Danaher Corp USA 2.40%
Pfizer Inc USA 2.37%
Visa Inc Class A USA 2.33%
Johnson & Johnson USA 2.28%
Medtronic PLC USA 2.13%
UnitedHealth Group Inc USA 2.08%
Dividend Date Per share amount Reinvestment Price
2nd January 2019 0.0875 £11.1742
2nd January 2018 0.0914 £11.0282